Barinthus Biotherapeutics plc (FRA:2AB)
0.5750
+0.0400 (7.48%)
Last updated: Aug 27, 2026, 8:03 AM CET
Barinthus Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -41.77 | -66.43 | -61.07 | -73.35 | 5.34 | -50.87 |
Depreciation & Amortization | 0.89 | 2.85 | 2.6 | 2.23 | 1.12 | 0.4 |
Other Amortization | 2.6 | 3 | 3.2 | 3.2 | 3.2 | 0.2 |
Loss (Gain) From Sale of Assets | -0.03 | -0.25 | - | - | -0.35 | - |
Asset Writedown & Restructuring Costs | 5.79 | 5.79 | 17.47 | - | - | - |
Stock-Based Compensation | 1.27 | 0.47 | 4.71 | 5.06 | 9.88 | 16.49 |
Other Operating Activities | 0.07 | 6.95 | 1.56 | 5.77 | -28.1 | 8.37 |
Change in Accounts Receivable | - | - | - | 5.8 | -5.83 | 0.56 |
Change in Accounts Payable | -1.2 | -2.2 | 0.9 | -3.38 | 1.14 | -3.53 |
Change in Unearned Revenue | -1.22 | -0.51 | 1.74 | - | -0.18 | -0.06 |
Change in Other Net Operating Assets | 7.17 | 2.35 | -0.04 | 3.75 | -0.65 | -4.15 |
Operating Cash Flow | -26.43 | -47.98 | -28.94 | -50.93 | -14.43 | -32.58 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | -0.04 | -0.89 | -5.41 | -6.14 | -1.15 |
Sale of Property, Plant & Equipment | 0.57 | 0.45 | - | - | 0.39 | - |
Cash Acquisitions | - | - | - | - | - | -11.77 |
Investing Cash Flow | 0.57 | 0.42 | -0.89 | -5.41 | -5.75 | -12.91 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Repaid | - | - | - | - | -0.16 | - |
Total Debt Repaid | - | - | - | - | -0.16 | - |
Net Debt Issued (Repaid) | - | - | - | - | -0.16 | - |
Issuance of Common Stock | - | 0 | 2.16 | 2.04 | 0.48 | 102.77 |
Other Financing Activities | - | - | - | -0.16 | - | -5.27 |
Financing Cash Flow | - | 0 | 2.16 | 1.87 | 0.33 | 222.74 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -2.3 | 7.01 | -2.02 | 2.17 | 0.19 | -6.46 |
Net Cash Flow | -28.15 | -40.55 | -29.69 | -52.3 | -19.67 | 170.79 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -26.43 | -48.02 | -29.83 | -56.34 | -20.57 | -33.73 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | - | -199.29% | -7024.69% | -46.01% | -12585.45% |
Free Cash Flow Per Share | -0.65 | -1.19 | -0.76 | -1.47 | -0.54 | -1.30 |
Levered Free Cash Flow | -6.17 | -28.04 | -16.29 | -42.35 | 1.64 | -16.54 |
Unlevered Free Cash Flow | -6.14 | -28.01 | -16.26 | -42.33 | 1.65 | -14.87 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | - | - | - | - | - | 1.84 |
Cash Income Tax Paid | - | - | - | - | - | 0.15 |
Change in Working Capital | 4.75 | -0.36 | 2.6 | 6.17 | -5.52 | -7.18 |